ProfileGDS4718 / 217824_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 79% 76% 68% 78% 80% 73% 76% 78% 77% 78% 79% 80% 73% 78% 79% 78% 76% 73% 72% 68% 78% 76% 81% 77% 81% 69% 81% 68% 75% 72% 71% 71% 80% 81% 68% 77% 72% 77% 77% 70% 74% 71% 65% 73% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.7001979
GSM549102patient 115, normal, homogenized [OPG study]7.3408176
GSM549104patient 119, normal, homogenized [OPG study]6.7682268
GSM549108patient 138, normal, homogenized [OPG study]7.5061478
GSM549119patient 077, normal, homogenized [OPG study]7.7854380
GSM549133patient 032, cancer, homogenized [OPG study]7.2703573
GSM549139patient 042, cancer, homogenized [OPG study]7.4133676
GSM549099patient 107, normal, homogenized [OPG study]7.5113778
GSM549109patient 139, normal, homogenized [OPG study]7.4915777
GSM549110patient 046, normal, homogenized [OPG study]7.6177878
GSM549114patient 063, normal, homogenized [OPG study]7.8430679
GSM549122patient 082, normal, homogenized [OPG study]7.8732180
GSM549134patient 033, cancer, homogenized [OPG study]7.1508173
GSM549136patient 036, cancer, homogenized [OPG study]7.7456478
GSM549140patient 044, cancer, homogenized [OPG study]7.838979
GSM549111patient 047, normal, homogenized [OPG study]7.6759778
GSM549113patient 057, normal, homogenized [OPG study]7.4893576
GSM549132patient 031, cancer, homogenized [OPG study]7.1360373
GSM549137patient 038, cancer, homogenized [OPG study]7.1240572
GSM549142patient 047, cancer, homogenized [OPG study]6.7410268
GSM549100patient 110, normal, homogenized [OPG study]7.5176578
GSM549107patient 135, normal, homogenized [OPG study]7.4819176
GSM549115patient 068, normal, homogenized [OPG study]8.0729781
GSM549116patient 072, normal, homogenized [OPG study]7.5464277
GSM549120patient 078, normal, homogenized [OPG study]7.9380281
GSM549131patient 030, cancer, homogenized [OPG study]6.7985769
GSM549118patient 074, normal, homogenized [OPG study]7.9476581
GSM549129patient 027, cancer, homogenized [OPG study]6.7973568
GSM549123patient 088, normal, homogenized [OPG study]7.3891675
GSM549124patient 006, cancer, homogenized [OPG study]7.042772
GSM549126patient 015, cancer, homogenized [OPG study]6.9584371
GSM549128patient 025, cancer, homogenized [OPG study]7.0811771
GSM549103patient 117, normal, homogenized [OPG study]7.6752780
GSM549117patient 073, normal, homogenized [OPG study]7.9536981
GSM549138patient 041, cancer, homogenized [OPG study]6.7258868
GSM549141patient 045, cancer, homogenized [OPG study]7.6201177
GSM549130patient 028, cancer, homogenized [OPG study]7.0517472
GSM549101patient 111, normal, homogenized [OPG study]7.4879777
GSM549105patient 128, normal, homogenized [OPG study]7.5226877
GSM549106patient 134, normal, homogenized [OPG study]6.9135670
GSM549112patient 048, normal, homogenized [OPG study]7.2161174
GSM549125patient 011, cancer, homogenized [OPG study]6.8986171
GSM549127patient 024, cancer, homogenized [OPG study]6.5815665
GSM549135patient 035, cancer, homogenized [OPG study]7.2395673